Mehmet Sofuoglu is a Psychiatry physician affiliated with Yale University. OpenAlex indexes 264 publications with 10,286 citations (h-index 59); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
950 Campbell Ave Bldg 36
West Haven, CT 065162770
Telephone
203-937-4809Registry record last updated 8 Jul 2007.
Clinical trials
- Impact of Sweeteners on the Addictive Threshold of Nicotine
Sponsor: Yale University
- IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
Sponsor: Yale University
- Nicotine Differences in Smokers
Sponsor: Yale University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
16 NIH research awards on record, funded 2003–2025 per NIH RePORTER. The latest:
- Addictive Threshold of Nicotine and the Impact of Sweeteners
Yale University
FY2025$288,126U54DA036151 - Addictive Threshold of Nicotine and the Impact of Sweeteners
Yale University
FY2024$348,552U54DA036151 - IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
Yale University
FY2023$392,233R01DA052566
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
Clinical Drug Investigation
2021 - Anhedonia as a Key Clinical Feature in the Maintenance and Treatment of Opioid Use Disorder
Clinical Psychological Science
2019 - Pharmacological and Behavioral Treatment of Opioid Use Disorder
Psychiatric Research and Clinical Practice
2018
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”